Phase 3 KEYNOTE-042 Study: Pembrolizumab vs Platinum-Based Chemotherapy as 1l Therapy for Advanced NSCLC with a PD-L1 TPS >= 1%
Date
2018Author
Mok, T.
Bondarenko, I.
Kubota, K.
Lubiniecki, G.
Zhang, J.
Kush, D.
Turna, H.
Lopes, G.
Wu, Y.
Kudaba, I.
Kowalski, D.
Cho, B.
De Castro, G.
Srimuninnimit, V.
Laktionov, K.
Metadata
Show full item recordCollections
- Makale [92796]